[go: up one dir, main page]

MA26625A1 - Conjugue de proteine hedgehog a activite accrue, procede pour sa production, et son utilisation therapeutique - Google Patents

Conjugue de proteine hedgehog a activite accrue, procede pour sa production, et son utilisation therapeutique

Info

Publication number
MA26625A1
MA26625A1 MA25560A MA25560A MA26625A1 MA 26625 A1 MA26625 A1 MA 26625A1 MA 25560 A MA25560 A MA 25560A MA 25560 A MA25560 A MA 25560A MA 26625 A1 MA26625 A1 MA 26625A1
Authority
MA
Morocco
Prior art keywords
production
hedgehog protein
therapeutic use
increased activity
protein conjugate
Prior art date
Application number
MA25560A
Other languages
English (en)
Inventor
Esswein Angelika
Lang Kurt
Seytter Tilmann
Rueger Petra
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP98107911A external-priority patent/EP0953575A1/fr
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Publication of MA26625A1 publication Critical patent/MA26625A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MA25560A 1998-04-30 1999-04-29 Conjugue de proteine hedgehog a activite accrue, procede pour sa production, et son utilisation therapeutique MA26625A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98107911A EP0953575A1 (fr) 1998-04-30 1998-04-30 Conjugué de proteine hedgehog active, procédé pour sa production et utilisation
EP98116733 1998-09-03

Publications (1)

Publication Number Publication Date
MA26625A1 true MA26625A1 (fr) 2004-12-20

Family

ID=26149214

Family Applications (1)

Application Number Title Priority Date Filing Date
MA25560A MA26625A1 (fr) 1998-04-30 1999-04-29 Conjugue de proteine hedgehog a activite accrue, procede pour sa production, et son utilisation therapeutique

Country Status (18)

Country Link
US (4) US6468978B1 (fr)
EP (2) EP1557427A3 (fr)
JP (1) JP3433136B2 (fr)
KR (1) KR19990083621A (fr)
CN (1) CN1233616A (fr)
AT (1) ATE308563T1 (fr)
AU (1) AU719797B2 (fr)
CA (1) CA2269221A1 (fr)
CY (1) CY1105683T1 (fr)
DE (1) DE69928040T2 (fr)
DK (1) DK0953576T3 (fr)
ES (1) ES2252886T3 (fr)
HU (1) HUP9901411A2 (fr)
IL (1) IL129620A (fr)
MA (1) MA26625A1 (fr)
NO (1) NO992090L (fr)
NZ (1) NZ335385A (fr)
SG (1) SG80028A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2312009A1 (fr) * 1997-11-28 1999-06-10 Roche Diagnostics Gmbh Mutant actif de proteine du herisson, son procede de preparation et son utilisation a des fins pharmaceutiques
US6897297B1 (en) * 1997-12-03 2005-05-24 Curis, Inc. Hydrophobically-modified protein compositions and methods
EP1557427A3 (fr) * 1998-04-30 2005-10-19 Curis, Inc. Conjugué de protein "hedgehog"
DE69928472T2 (de) 1998-08-07 2006-08-10 Curis, Inc., Cambridge Stabilisierte pharmazeutische Zusammensetzungen von Hedgehog-Proteinen und deren Verwendung
TW570805B (en) 1998-09-01 2004-01-11 Hoffmann La Roche Water-soluble pharmaceutical composition in an ionic complex
CA2352570A1 (fr) * 1998-12-03 2000-06-22 Biogen, Inc. Procedes et compositions servant a traiter des troubles entrainant une excitotoxicite
EP1025861A1 (fr) * 1999-02-04 2000-08-09 Roche Diagnostics GmbH Compositions pharmaceutiques des Proteines Hedgehog rendues hydrophobes, et leur utilisation
WO2000073337A1 (fr) * 1999-06-01 2000-12-07 Biogen, Inc. Conjugues polymeres de proteines hedgehog et leurs utilisations
AU2001255767A1 (en) * 2000-04-28 2001-11-12 Curis, Inc. Methods and reagents for tissue engineering of cartilage in vitro
US7573637B2 (en) * 2004-08-03 2009-08-11 Seiko Epson Corporation Intrinsic polarizer and method of manufacturing an intrinsic polarizer
US8669418B2 (en) * 2005-12-22 2014-03-11 Vib Vzw Means and methods for mediating protein interference
US20100316566A1 (en) * 2008-02-27 2010-12-16 Radiomedix Inc. Radiolabeled hedgehog derivatives for imaging and therapy
US20100172889A1 (en) * 2008-12-05 2010-07-08 Catchmark Jeffrey M Degradable biomolecule compositions
US20110086236A1 (en) * 2009-10-13 2011-04-14 The Penn State Research Foundation Composites containing polypeptides attached to polysaccharides and molecules
KR20140038501A (ko) * 2011-06-06 2014-03-28 키네타 원, 엘엘씨 Shk-기초된 제약학적 조성물 및 이들을 제조하고 이용하는 방법
EP4349899A1 (fr) 2013-07-26 2024-04-10 The Penn State Research Foundation Compositions polymères et revêtements
WO2017095201A1 (fr) * 2015-12-02 2017-06-08 한미약품 주식회사 Complexe protéique faisant appel à un dérivé d'acide gras, et son procédé de préparation

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364839A (en) * 1990-06-18 1994-11-15 Genetics Institute, Inc. Osteoinductive pharmaceutical formulations
EP0513334A4 (en) * 1990-11-30 1993-08-04 Celtrix Laboratories, Inc. Use of a bone morphogenetic protein in synergistic combination with tgf--g(b) for bone repair
US5789543A (en) * 1993-12-30 1998-08-04 President And Fellows Of Harvard College Vertebrate embryonic pattern-inducing proteins and uses related thereto
AU704178B2 (en) * 1993-12-30 1999-04-15 Imperial Cancer Research Technology Ltd Vertebrate embryonic pattern-inducing hedgehog-like proteins
US6281332B1 (en) * 1994-12-02 2001-08-28 The Johns Hopkins University School Of Medicine Hedgehog-derived polypeptides
US5700774A (en) * 1996-03-26 1997-12-23 Genetics Institute, Inc. Compositions comprising bone morphogenic proteins and truncated parathyroid hormone related peptide, and methods of inducing cartilage by administration of same
GB9614871D0 (en) 1996-07-15 1996-09-04 Smithkline Beecham Plc Compounds
JP2002503088A (ja) * 1996-10-07 2002-01-29 ザ ジョーンズ ホプキンス ユニバーシティー スクール オブ メディシン 新規ヘッジホッグ由来ポリペプチド
CA2312009A1 (fr) * 1997-11-28 1999-06-10 Roche Diagnostics Gmbh Mutant actif de proteine du herisson, son procede de preparation et son utilisation a des fins pharmaceutiques
US6897297B1 (en) * 1997-12-03 2005-05-24 Curis, Inc. Hydrophobically-modified protein compositions and methods
NZ504752A (en) * 1997-12-03 2002-10-25 Biogen Inc Hydrophobically-modified protein compositions (particularly hedgehog proteins)
EP1557427A3 (fr) * 1998-04-30 2005-10-19 Curis, Inc. Conjugué de protein "hedgehog"
DE69928472T2 (de) * 1998-08-07 2006-08-10 Curis, Inc., Cambridge Stabilisierte pharmazeutische Zusammensetzungen von Hedgehog-Proteinen und deren Verwendung
AU2001255767A1 (en) * 2000-04-28 2001-11-12 Curis, Inc. Methods and reagents for tissue engineering of cartilage in vitro

Also Published As

Publication number Publication date
CY1105683T1 (el) 2010-12-22
HU9901411D0 (en) 1999-07-28
EP1557427A2 (fr) 2005-07-27
AU2500999A (en) 1999-11-11
SG80028A1 (en) 2001-04-17
US7153836B2 (en) 2006-12-26
DK0953576T3 (da) 2006-03-20
EP1557427A3 (fr) 2005-10-19
KR19990083621A (ko) 1999-11-25
NO992090D0 (no) 1999-04-29
NZ335385A (en) 2000-09-29
US20050148510A1 (en) 2005-07-07
ATE308563T1 (de) 2005-11-15
AU719797B2 (en) 2000-05-18
US20070191274A1 (en) 2007-08-16
ES2252886T3 (es) 2006-05-16
US6468978B1 (en) 2002-10-22
JP3433136B2 (ja) 2003-08-04
CA2269221A1 (fr) 1999-10-30
IL129620A0 (en) 2000-02-29
IL129620A (en) 2009-06-15
EP0953576B1 (fr) 2005-11-02
US20030139574A1 (en) 2003-07-24
EP0953576A1 (fr) 1999-11-03
DE69928040D1 (de) 2005-12-08
NO992090L (no) 1999-11-01
DE69928040T2 (de) 2006-07-27
US6818623B2 (en) 2004-11-16
CN1233616A (zh) 1999-11-03
HUP9901411A2 (hu) 1999-12-28
JP2000053699A (ja) 2000-02-22

Similar Documents

Publication Publication Date Title
MA26625A1 (fr) Conjugue de proteine hedgehog a activite accrue, procede pour sa production, et son utilisation therapeutique
EP0401199A3 (fr) Méthode de préparation d'un matériau pour implant biologique
MA21169A1 (fr) Acides desoxyribonucleiques et procede de preparation des proteines qui en derivant.
DE3774274D1 (de) Solubilisierung von proteinen fuer pharmazeutsche zusammensetzungen.
DE69830240D1 (de) Hyaluronsäure-gel, verfahren zur dessen herstellung und hyaluronsäure-gel enthaltendes medizinisches material
IT8947794A0 (it) Proteine biologicamente attive, formulazioni che le contengono e metodo per prepararle ed applicarle
HU9200548D0 (en) Improved activity process of recombined proteins
AU1402788A (en) Vascular anticoagulant proteins
EP0036277A3 (en) Activated liposomes, method of producing them and protein coupling method using them
PT88275A (pt) Processo para a preparacao de composicoes farmaceuticas contendo 5-amino ou amino substituido-1,2,3-triazois uteis como agentes antiproliferativos
ATE84716T1 (de) 4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelialgewebekrankheiten.
DE69011622D1 (de) Verwendung von geschützten Aminosäuren in Futtermitteln für Schafe.
PT91006A (pt) Processo para a preparacao de um novo sal de estroncio
DK292584D0 (da) Biologisk aktive konjugater, deres fremstilling og anvendelse
DK269685A (da) Basebehandlet hydrogel
PT91415A (pt) Processo para a preparacao de novos derivados de furiltiazol
DE69019543D1 (de) Verfahren zur Herstellung biologisch aktiver Polysaccharid-RON-Substanz.
BR9604843A (pt) Peptìdeo e derivado do mesmo, e, droga e composição para tratar osteopatia
FR2708202B1 (fr) Implant biocompatible pour l'expression chez l'homme ou chez l'animal de substances déterminées.
UA10281C2 (uk) Спосіб отримання речовини для лікування захворювань підшлункової залози
DE3685988D1 (de) Verwendung von "naftidrofuryl" zur behandlung von neuropathien.
FR2645865B1 (fr) Procede de preparation de la proteine c activee et solution de proteine c activee ainsi obtenue
NO900616L (no) Fremgangsmaate for fraksjonering av avlinger i industrieltraamateriale.